Compare RUN & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RUN | INSP |
|---|---|---|
| Founded | 2007 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Industrial Machinery/Components | Medical/Dental Instruments |
| Sector | Miscellaneous | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.1B | 2.2B |
| IPO Year | 2015 | 2018 |
| Metric | RUN | INSP |
|---|---|---|
| Price | $7.81 | $59.00 |
| Analyst Decision | Buy | Hold |
| Analyst Count | 19 | 18 |
| Target Price | $13.59 | ★ $69.38 |
| AVG Volume (30 Days) | ★ 10.8M | 583.3K |
| Earning Date | 11-04-2026 | 11-02-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | 113.35 | ★ 179.43 |
| EPS | ★ 1.60 | N/A |
| Revenue | ★ $858,578,000.00 | $82,050,000.00 |
| Revenue This Year | $19.80 | N/A |
| Revenue Next Year | N/A | $2.61 |
| P/E Ratio | $4.83 | ★ N/A |
| Revenue Growth | 12.97 | ★ 62.18 |
| 52 Week Low | $6.78 | $38.91 |
| 52 Week High | $21.95 | $147.03 |
| Indicator | RUN | INSP |
|---|---|---|
| Relative Strength Index (RSI) | 44.28 | 32.10 |
| Support Level | $6.94 | $56.50 |
| Resistance Level | $7.86 | $59.40 |
| Average True Range (ATR) | 0.69 | 2.72 |
| MACD | -0.06 | -0.90 |
| Stochastic Oscillator | 16.40 | 5.09 |
Sunrun is engaged in the design, development, installation, sale, ownership, and maintenance of residential solar energy systems in the United States. The company acquires customers directly and through relationships with various solar and strategic partners. The solar systems are constructed by Sunrun or by Sunrun's partners and are owned by the company. Sunrun's customers typically enter into 20- to 25-year agreements to utilize its solar energy system. The company also sells solar energy systems and products, such as panels and racking, and solar leads generated to customers.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and All other countries wherein, it generates a majority of its revenue from the United States. Its segment revenues are derived from the sales of its product, the Inspire system, to hospitals and ambulatory surgery centers in the U.S. and in selected countries in Europe and the Asia Pacific region.